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Objective: Several clinical and left ventricular parameters have been associated
with prognosis after surgical left ventricular restoration in patients with ischemic
heart failure. The aim of this study was to determine the prognostic value of right
ventricular function.
Methods: A total of 139 patients with ischemic heart failure (62 10 years; 79%
were male; left ventricular ejection fraction 27%  7%) underwent surgical left
ventricular restoration. Biventricular function was assessed with echocardiography
before surgery. The independent association between all-cause mortality and right
ventricular fractional area change, tricuspid annular plane systolic excursion, and
right ventricular longitudinal peak systolic strain was assessed. The additive effect
of multiple impaired right ventricular parameters on mortality also was assessed.
Results: Baseline right ventricular fractional area change was 42%  9%,
tricuspid annular plane systolic excursion was 18  3 mm, and right ventricular
longitudinal peak systolic strain was 24%  7%. Within 30 days after surgery,
15 patients died. Right ventricular fractional area change (hazard ratio, 0.93; 95%
confidence interval, 0.88-0.98; P<.01), tricuspid annular plane systolic excursion
(hazard ratio, 0.80; 95% confidence interval, 0.66-0.96; P ¼ .02), and right ven-
tricular longitudinal peak systolic strain (hazard ratio, 1.15; 95% confidence in-
terval, 1.05-1.26; P < .01) were independently associated with 30-day
mortality, after adjusting for left ventricular ejection fraction and aortic cross-
clamping time. Right ventricular function was impaired in 21%, 20%, and
27% of patients on the basis of right ventricular fractional area change, tricuspid
annular plane systolic excursion, and right ventricular longitudinal peak systolic
strain, respectively. Any echocardiographic parameter of right ventricular
dysfunction was present in 39% of patients. The coexistence of several impaired
right ventricular parameters per patient was independently associated with
increased 30-day mortality (hazard ratio, 2.83; 95% confidence interval, 1.64-
4.87, P<.01 per additional impaired parameter).
Conclusions: Baseline right ventricular systolic dysfunction is independently asso-
ciated with increased mortality in patients with ischemic heart failure undergoing
surgical left ventricular restoration. (J Thorac Cardiovasc Surg 2017;153:845-52)From the aDepartment of Cardiology, Leiden UniversityMedical Centre, Leiden, The
Netherlands; bDepartment of Cardiothoracic Surgery, Leiden University Medical
Centre, Leiden, The Netherlands; cDepartment of Medical Statistics and Bioinfor-
matics, Leiden University Medical Centre, Leiden, The Netherlands; and dMathe-
matical Institute, Leiden University, Leiden, The Netherlands.
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Central Message
Baseline RV systolic dysfunction is indepen-
dently associated with increased mortality in
patients with ischemic heart failure undergoing
surgical ventricular restoration.Perspective
RV dysfunction is frequent in patients with
heart failure undergoing surgical ventricular
restoration and is independently associated
with increased 30-day mortality. The coexis-
tence of multiple impaired RV parameters
further increases mortality. Perioperative mea-
sures for RV protection or refraining from sur-
gery should be carefully considered in surgical
candidates with RV dysfunction.See Editorial Commentary page 853.
See Editorial page 843.Surgical ventricular restoration (SVR) of the left ventricle
(LV) in addition to coronary revascularization yields a sur-
vival benefit compared with revascularization alone if thepredicted postoperative LV end-systolic volume index is
70 mL/m2 or less. This is the outcome of a substudy of the
Surgical Treatment for Ischemic Heart Failure trial in whichia L. M. A. Beeres, MD, PhD, Department of Cardiology,
dical Center, PO Box 9600, 2300 RC Leiden, The
.m.a.beeres@lumc.nl).
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Abbreviations and Acronyms
CABG ¼ coronary artery bypass grafting
CI ¼ confidence interval
HR ¼ hazard ratio
LV ¼ left ventricular
LVAD ¼ left ventricular assist device
LVEF ¼ left ventricular ejection fraction
NYHA ¼ New York Heart Association
RV ¼ right ventricular
RVFAC ¼ right ventricular fractional area change
RV LPSS ¼ right ventricular longitudinal peak
systolic strain
SVR ¼ surgical ventricular restoration
TAPSE ¼ tricuspid annular plane systolic
excursion
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1000 patients with ischemic heart failure and anterior akine-
sia or dyskinesia were randomized to coronary artery bypass
grafting (CABG) surgery alone or combined with SVR.1
Other factors thatmay affect outcome in patients undergoing
SVR include poor LV function, high preoperative LV end-
systolic volume index, and New York Heart Association
(NYHA) functional class IV.2-4 So far, only limited data
are available on the influence of right ventricular (RV)
function and dimensions on outcome after SVR.5,6 The
reduction in LV volume after SVR may lead to increased
LV filling pressures and increased afterload of the right
ventricle that may decrease its function. Furthermore, the
improvement in LV systolic function after SVR may lead
to increased preload of the right ventricle. Preoperative
impaired RV systolic function may have a negative impact
on outcome after SVR, because the right ventricle may not
be able to handle the increased preload and afterload.
Therefore, preoperative RV systolic function might be an
important variable to consider in the selection of patients
with ischemic heart failure who may be candidates for
SVR. The purpose of the present study was to assess
whether RV function is associated with postoperative
survival in patients with heart failure undergoing SVR.
MATERIALS AND METHODS
Study Population and Protocol
The study population comprised 143 consecutive patients who under-
went SVR according to the technique described by Dor between January
2006 and January 2014.7 All patients had symptomatic heart failure despite846 The Journal of Thoracic and Cardiovascular Surgoptimal medication and a postinfarction LV aneurysm. The decision to
perform SVR was made by the institutional multidisciplinary heart team.
Exclusion criteria for the current study were incomplete follow-up
(N ¼ 2) and insufficient preoperative transthoracic echocardiographic im-
age quality for the current analysis (N ¼ 2). According to the institutional
protocol, all patients underwent clinical and echocardiographic evaluation
before SVR. Clinical data, including demographic characteristics, medical
history, comorbidities, and functional status according to the NYHA clas-
sification, were prospectively collected in the departmental cardiology in-
formation system (EPD-Vision, Leiden UniversityMedical Center, Leiden,
The Netherlands) and retrospectively analyzed. Creatinine clearance was
estimated using the Cockcroft–Gault formula.8 All-cause mortality was
registered during 30 days of follow-up through case record review and
the national death registry. The study was conducted in accordance with
the Declaration of Helsinki. The institutional ethical committee approved
this retrospective evaluation of clinically acquired data.
Transthoracic Echocardiography
In line with the institutional protocol, routine transthoracic
echocardiography was performed before SVR. Images were obtained with
the patient in the left lateral decubitus and supine position with a
commercially available system (Vivid 7 or E9; General Electric-Vingmed,
Horten, Norway) and digitally stored in cine-loop format. For the present
study, measurements were performed by a cardiologist specialized in
echocardiography using commercially available software (EchoPAC version
112.0.1;GeneralElectric-VingmedUltrasoundAS).For the assessment ofLV
systolic function, LVend-systolic and end-diastolic volumes were measured
from the apical 4- and 2-chamber views, and LVejection fraction (LVEF)was
calculated using the Simpson’s biplane technique.9 LV end-systolic volume
was indexed for body surface area to obtain LV end-systolic volume index.
End-diastolic left atrial volume was measured in the apical 4- and
2-chamber views and indexed for body surface area to obtain left atrial
volume index.9 Peak early diastolic mitral inflow velocity was measured on
pulsed-wave Doppler recordings, and septal and lateral early diastolic mitral
annulus velocities were measured on tissue Doppler imaging of the apical
4-chamber view. Peak early diastolic mitral inflow velocity was divided by
the average of septal and lateral annular velocities to acquire the peak early
diastolic mitral inflow velocity/early diastolic mitral annulus velocity ratio.10
For comprehensive RV functional assessment, RV end-systolic and end-
diastolic areas were traced in the RVapical view to calculate fractional area
change (right ventricular fractional area change [RVFAC]). Tricuspid annular
plane systolic excursion (TAPSE) was calculated on M-mode recordings of
the lateral tricuspid annulus in the RV apical view. Furthermore,
speckle-tracking echocardiography of the RV free wall was performed. RV
longitudinal peak systolic strain (RV LPSS) was measured in the basal,
midventricular, and apical segments of the RV free wall, and global RV
LPSS was calculated as the average of the 3 measurements. Cutoff values
for impaired RV functional parameters were derived from the most recent
American Society of Echocardiography recommendations for cardiac cham-
ber quantification, and assessment of the right heart was assessed by echocar-
diography in adults and defined as RVFAC less than 35%, TAPSE less than
16 mm, and RV LPSS greater than 20%.9,11 The diameter of the
tricuspid valve annulus was measured during diastole on the apical RV
view.12 The maximum tricuspid regurgitant jet gradient was measured from
continuous-wave Doppler using the modified Bernoulli equation.11 Right
atrial pressurewas estimated as 3, 8, or 15mmHgon the basis of the diameter
and inspiratory collapse of the inferior caval vein in the subcostal view.9 Sys-
tolic pulmonaryarterial pressurewascalculatedbysummationof the tricuspid
regurgitant jet gradient and right atrial pressure. Pulmonary hypertensionwas
defined as systolic pulmonary arterial pressure greater than 50 mm Hg.13
Surgical Left Ventricular Restoration
The details of the SVR procedure according to Dor have been
described.7,14 All operations were performed using cardiopulmonaryery c April 2017
TABLE 1. Baseline characteristics and hazards ratios for univariable Cox regression analysis of 30-day mortality
N ¼ 139
30-d mortality
HR 95% CI P value
Clinical and surgical characteristics
Age at operation (y) 62  10 1.02 0.97-1.08 .50
Male sex (%) 79 1.77 0.40-7.83 .45
NYHA functional class 3 or 4 55 3.38 0.95-11.97 .06
Creatinine clearance (mL/min) 79  28 1.00 0.98-1.02 .92
euroSCORE II (%) 5 (IQR, 3-12) 1.05 1.02-1.08 <.01
Previous sternotomy (%) 12 1.90 0.54-6.73 .32
Nonelective surgery (%) 21 4.68 1.69-12.90 <.01
Aortic crossclamping time (min) 148  69 1.01 1.00-1.01 <.01
Concomitant procedures (%) 90 23.83 0.02-32344.19 .39
CABG (%) 53 3.81 1.07-13.50 .04
MV surgery (%) 53 1.86 0.63-5.43 .26
TV surgery (%) 26 1.40 0.48-4.10 .54
VT ablation (%) 42 0.70 0.24-2.04 .51
Echocardiographic characteristics
LVEF (%) 27  7 0.93 0.87-0.99 .03
LVESVI (mL/m2) 87  41 1.00 0.99-1.01 .64
LAVI (mL/m2) 46  18 1.02 0.99-1.04 .23
E/E0 ratio 18  9 1.02 0.96-1.08 .55
RVFAC (%) 42  9 0.92 0.88-0.97 <.01
TAPSE (mm) 18  3 0.78 0.65-0.94 <.01
RV LPSS (%) 24  7 1.14 1.04-1.24 <.01
TV annulus (mm) 32  6 1.08 0.99-1.17 .07
TR grade 2 (%) 19 1.56 0.50-4.89 .45
Pulmonary hypertension 12 1.89 0.53-6.70 .32
Bold signifies statistical significance. HR, Hazard ratio; CI, confidence interval; NYHA, New York Heart Association; euroSCORE, European System for Cardiac Operative Risk
Evaluation; IQR, interquartile range; CABG, coronary artery bypass grafting; MV, mitral valve; TV, tricuspid valve; VT, ventricular tachycardia; LVEF, left ventricular ejection
fraction; LVESVI, left ventricular end-systolic volume index; LAVI, left atrial volume index; E/E0 , peak early diastolic mitral inflow velocity/early diastolic mitral annulus ve-
locity; RVFAC, right ventricular fractional area change; TAPSE, tricuspid annular plane systolic excursion; RV LPSS, right ventricular longitudinal peak systolic strain; TR,
tricuspid regurgitation.




bypass, aortic crossclamping, and intermittent warm blood cardioplegia. In
summary, the LVwas opened through the infarcted area and a Fontan stitch
was placed at the transitional zone between viable and scarred
myocardium. A mannequin balloon (TRISVR, Chase Medical,
Richardson, Tex) was used to determine both the new size and the shape
of the residual LV cavity. For size, the balloon was filled at 55 mL/m2
body surface area. The balloon also allowed proper orientation of the
neo-apex and the patch used to close the defect, which was sutured in a
way directed obliquely at the aortic outflow tract to ensure an elliptical
shape and avoid a boxlike or spherical shape. Concomitant procedures
were performed when indicated. Nonelective surgery was defined as sur-
gery performed during an urgent admission.
Statistical Analysis
Continuous variables are expressed as mean standard deviation when
normally distributed or otherwise as median and interquartile range. Cate-
goric data are presented as frequencies and percentages. Univariable Cox
regression analysis was performed to assess the association between 30-
day mortality and baseline clinical, surgical, and echocardiographic param-
eters by estimating the hazard ratio (HR) and 95% confidence interval (CI).
Kaplan–Meier survival curves and 95% CI for patients with normal versus
impaired echocardiographic indices of RV function were estimated. Signif-
icant variables in the univariable analysis were entered in several non-
nested multivariable analyses. Regression analysis was performed on 15
events, and 1 variable was entered for every 5 events in the multivariable
analysis. LVEF and aortic crossclamping time were considered the clini-
cally most relevant variables and were included in the multivariableThe Journal of Thoracic and Caanalysis along with 1 RV parameter per model. Furthermore, patients
were classified as having no, 1, 2, or 3 impaired RV parameters. The asso-
ciation between the number of impaired RV parameters and mortality was
assessed using Cox proportional hazard regression models. To define the
intraobserver and interobserver variability, measurements for RV func-
tional parameters were repeated for 20 randomly selected patients by the
same observer and a second independent observer, both unaware of clinical
outcome. Intraobserver and interobserver variability were assessed using
Bland–Altman analysis and are expressed as mean difference  standard
deviation. Statistical analysis was performed by using SPSS for Windows
(version 23.0, Armonk, NY).RESULTS
Baseline Clinical and Echocardiographic Data
In total, 139 patients with heart failure (mean age,
62  10 years; 79% were male) were included. Table 1
summarizes baseline clinical and echocardiographic data.
Baseline NYHA functional class was 3 or 4 in 77 patients
(55%), and mean LVEF was 27%  7%. The median Eu-
ropean System for Cardiac Operative Risk Evaluation II
was 5% (interquartile range, 3%-12%). Nonelective sur-
gery was performed in 29 patients (21%). Echocardio-
graphic assessment of RVFAC, TAPSE, and RV LPSS
was feasible in 136 patients (98%), 137 patients (99%),rdiovascular Surgery c Volume 153, Number 4 847
FIGURE 1. Kaplan–Meier survival curves for baseline normal versus impaired RV function in patients after SVR. A, RVFAC. B, TAPSE. C, RV LPSS.
RVFAC, Right ventricular fractional area change; TAPSE, tricuspid annular plane systolic excursion; RV LPSS, right ventricular longitudinal peak systolic
strain; SVR, surgical ventricular restoration. Dashed lines: 95% CI.
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and 117 patients (84%), respectively. Mean RVFAC was
42%  9%, mean TAPSE was 18  3 mm, and mean RV
LPSS was 24%  7%. RVFAC was impaired in 29 pa-
tients (21%), TAPSE was impaired in 27 patients (20%),
and RVLPSS was impaired in 31 patients (27%). In 114 pa-
tients, all 3 measurements of RVFAC, TAPSE, and RV
LPSS could be assessed. In this population, 44 patients848 The Journal of Thoracic and Cardiovascular Surg(39%) had 1 or more parameters of impaired RV function.
Bland–Altman analysis showed good intraobserver and
interobserver agreement. Mean differences were
0.41  2.66 for RVFAC, 0.25  1.29 for TAPSE, and
0.07  2.28 for RV LPSS for interobserver variability and
0.60  2.78 for RVFAC, 0.05  0.69 for TAPSE, and
0.10  1.48 for RV LPSS for intraobserver variability.ery c April 2017
TABLE 2. Multivariable Cox regression analysis of 30-day mortality and right ventricular function: Correlates of 30-day mortality including
RVFAC, TAPSE, and RV LPSS
Univariable analysis Multivariable analysis
HR 95% CI P value HR 95% CI P value
RVFAC
LVEF (%) 0.93 0.87-0.99 .03 0.91 0.84-0.99 .03
Aortic crossclamping time (min) 1.01 1.00-1.01 <.01 1.01 1.0-1.01 <.01
RVFAC 0.92 0.88-0.97 <.01 0.93 0.88-0.98 <.01
TAPSE
LVEF (%) 0.93 0.87-0.99 .03 0.94 0.86-1.02 .12
Aortic crossclamping time (min) 1.01 1.00-1.01 <.01 1.01 1.0-1.01 <.01
TAPSE 0.78 0.65-0.94 <.01 0.80 0.66-0.96 .02
RV LPSS
LVEF (%) 0.93 0.87-0.99 .03 0.95 0.87-1.03 .17
Aortic crossclamping time (min) 1.01 1.00-1.01 <.01 1.01 1.0-1.01 <.01
RV LPSS 1.14 1.04-1.24 .01 1.15 1.05-1.26 <.01
Bold signifies statistical significance. HR, Hazard ratio; CI, confidence interval; RVFAC, right ventricular fractional area change; LVEF, left ventricular ejection fraction; TAPSE,
tricuspid annular plane systolic excursion; RV LPSS, right ventricular longitudinal peak systolic strain.




Surgical Data and Postoperative Survival
At the time of SVR, concomitant CABG, mitral valve
surgery, and tricuspid valve surgery were performed in 74
patients (53%), 73 patients (53%), and 36 patients
(26%), respectively. Ablation for ventricular tachycardias
was performed in 58 patients (42%) and included endocar-
dial resection in 11 patients (8%). Mean aortic crossclamp-
ing time was 148  69 minutes. Within 30 days after
surgery, 15 patients died, yielding a survival of 89%. All
15 deaths within the first 30 days were heart failure related,
and 10 of 15 patients (67%) clinically experienced postop-
erative RV failure. In 8 of 15 patients (53%), mechanical
support (intra-aortic balloon pump or extracorporeal mem-
brane oxygenation) was used postoperatively to attempt to
support cardiac function.Associates of 30-Day Survival
Univariable Cox regression analysis revealed that the Eu-
ropean System for Cardiac Operative Risk Evaluation II,
nonelective surgery, aortic crossclamping time, CABG,
LVEF, RVFAC, TAPSE, and RV LPSS were associated
with 30-day mortality (Table 1). As shown in Figure 1,
the 30-day survivals of patients dichotomized on the basis
of RVFAC 35% or more or less than 35% were 94% and
69%, respectively (P< .01). Likewise, at 30-day follow-
up, higher survival was observed in patients with TAPSE
16 mm or greater compared with patients with TAPSE
less than 16 mm (94% vs 70%, P< .01) and in patients
with RV LPSS 20% or less compared with patients with
RV LPSS greater than 20% (94% vs 74%, P < .01).
Multivariable Cox regression analysis was performed to
assess the association between each separate continuous
parameter of RV function and 30-day mortality, adjusted
for LVEF and aortic crossclamping time. As shown in
Table 2, the multivariable analysis revealed that RVFACThe Journal of Thoracic and Ca(HR, 0.93; 95% CI, 0.88-0.98; P < .01), TAPSE (HR,
0.80; 95% CI, 0.66-0.96; P ¼ .02), and RV LPPS (HR,
1.15; 95% CI, 1.05-1.26; P<.01) remained independently
associated with 30-day mortality, after adjusting for LVEF
and aortic crossclamping time. Subsequently, the additive
effect of multiple impaired RV parameters on mortality
was investigated. The 30-day survival was 97% in patients
with no echocardiographic parameters of impaired RV
function, 83% in patients with 1 impaired parameter,
73% in patients with 2 impaired parameters, and 40% in
patients with 3 parameters of impaired RV function
(P < .01), as shown in Figure 2. On multivariable Cox
regression analysis, the coexistence of several impaired
RV parameters per patient remained independently associ-
ated with increased 30-day mortality (HR, 2.83; 95% CI,
1.64-4.87; P<.01 per additional impaired parameter) after
adjusting for LVEF and aortic crossclamping time. The re-
sults are also presented in Video 1.DISCUSSION
The main finding of the current study is that preoperative
RV dysfunction was an important determinant of postoper-
ative survival in patients with ischemic heart failure under-
going SVR. In particular, reduced RVFAC, TAPSE, and RV
LPSS as assessed by echocardiography were independently
associated with increased 30-day mortality. Furthermore, a
higher number of impaired RV parameters per patient was
associated with increased mortality.
Impaired RV function, as assessed with a wide variety of
parameters, is a well-known risk factor for mortality in the
general population with heart failure.15-20 Previous studies
also demonstrated that RV function is a prognostic marker
in patients with heart failure undergoing cardiac surgery.
Maslow and colleagues21 showed that baseline RV dysfunc-
tion was associated with poor outcome in patients withrdiovascular Surgery c Volume 153, Number 4 849
FIGURE 2. Kaplan–Meier survival curves for the coexistence of multiple
parameters of impaired RV function in patients after SVR. Patients with no,
1, 2, and 3 parameters of impaired RV function. SVR, Surgical ventricular
restoration. Dashed lines: 95% CI.
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severe LV dysfunction undergoing CABG. Furthermore,
Dandel and colleagues22 showed an association between
preoperative RV function and outcome in patients undergo-
ing LV assist device (LVAD) implantation and emphasized
the additive value of combining RV parameters to quantify
RV function.
Conceptually, RV function also may be an important prog-
nostic determinant after SVR. Previous studies reported that
SVR enhances LV systolic function but also can impair LV
diastolic properties, resulting in elevation of LV filling pres-
sures and increased RV afterload.23-25 Furthermore, the
more spherical LV geometry after SVR alters the position
and function of the interventricular septum, which may
influence RV geometry and function.26,27 Therefore,
preoperative assessment of RV function seems to be an
important variable to consider in patient selection for SVR.
Data associating RV function and outcome in patients
with ischemic heart failure undergoing SVR are scarce.
Kukulski and colleagues5 examined the prevalence of RV
dysfunction and its effect on outcome in a subgroup ofVIDEO 1. RV dysfunction affects survival after SVR. Description of the
methods and main outcomes of the present study, including details on the
echocardiographic measurements and surgical procedure. Video available
at: http://www.jtcvsonline.org/article/S0022-5223(16)31156-4/addons.
850 The Journal of Thoracic and Cardiovascular Surg866 patients included in the Surgical Treatment for
Ischemic Heart Failure trial. RV dysfunction was visually
assessed with echocardiography and classified as mild in
12% of patients and moderate to severe in 9% of patients.
The grade of RV dysfunction was associated with advanced
LV remodeling and worse hemodynamic profiles. Patients
with moderate to severe RV dysfunction who received
CABG and SVR had significantly higher mortality and car-
diovascular hospitalization rates at long-term follow-up
compared with patients who received CABG alone. Kukul-
ski and colleagues5 concluded that adding SVR to CABG
may worsen survival in patients with moderate to severe
RV dysfunction. However, it should be noted that visual
classification of RV dysfunction is difficult to categorize
and may be inaccurate and with poor interobserver
agreement.
Furthermore, Garatti and colleagues6 assessed the rela-
tion between RV function and clinical outcome after
SVR. A total of 324 patients underwent SVR, and concom-
itant CABG was performed in 90% of patients. RV
dysfunction, defined as TAPSE less than 16 mm, was
present in 21% of patients and associated with a higher
frequency of so-called low-output syndrome, postoperative
inotropic support, and intra-aortic balloon pump insertion.
In this study, no statistically significant difference in
30-day survival was found between patients with and
without RV dysfunction, but 5- and 8-year survivals and
freedom from cardiac events were significantly lower in pa-
tients with preoperative RV dysfunction. However, it has to
be noted that TAPSE is only an approximate indicator of RV
function that does not reflect the complex geometry and
function of the right ventricle.
Similar to these studies, the present study confirmed the
association between RV dysfunction and increased mortal-
ity after SVR. However, our data extend the insights into
this association by adding the assessment of RV function
based on myocardial strain. RV LPSS is a novel measure-
ment that assesses free wall deformation independently of
the angle of the ultrasound beam.9,28 In addition, the use
of standardized measuring techniques and generally
acknowledged cutoff values make our findings easily
reproducible for future patients considered for SVR.9,11
Comprehensive echocardiographic assessment of multiple
RV functional parameters revealed a higher proportion of
patients with any sign of RV dysfunction compared with
previous studies (39% RV dysfunction in the present
study vs 21% in studies by Kukulski and colleagues5 and
Garatti and colleagues6). Our findings demonstrate for the
first time that a higher number of impaired RV parameters
per patient had an incremental worse effect on 30-day sur-
vival. Furthermore, Kukulski and colleagues5 showed that
RV dysfunction was associated with advanced LV remodel-
ing and proposed that the negative effect of RV dysfunction
on outcome after SVR was dependent on this association.ery c April 2017




The present study is the first to demonstrate that impaired
RV function is an independent marker for worse survival
in patients undergoing SVR, after adjusting for LVEF.
Consequently, the current study increases knowledge on
the diagnosis and implications of RV impairment in patients
undergoing SVR.Study Limitations
First, echocardiographic evaluation of the right ventricle
is subject to adequate visualization of its complex 3-dimen-
sional geometry and dependent on the RV preload and after-
load.22,29 Furthermore, because of the retrospective nature
of this study, no information is available regarding
patients rejected for SVR. Therefore, comparison on
survival between operated and nonoperated patients with
RV dysfunction could not be performed.Clinical Implications
The current study emphasizes the importance of patient
selection for SVR, because postoperative mortality is
significantly increased in patients with preexistent RV
dysfunction. Comprehensive echocardiography using mul-
tiple measuring techniques is essential to characterize over-
all RV function. Patients with RV dysfunction could benefit
from additional perioperative measures for RV protection,
such as the use of inhaled nitric oxide. Otherwise, refraining
from SVR should be considered carefully in patients at
increased risk for postoperative RV failure. Apart from
heart transplant, an alternative treatment option in those pa-
tients might even be LVAD implantation because previous
studies showed that mechanical unloading of the LV de-
creases LV filling pressures and thereby reduces RV after-
load.30,31 Nonetheless, it has to be noted that LVAD
implantation brings its own challenges to RV function.22,32CONCLUSIONS
Preexistent RV dysfunction in patients with ischemic
heart failure undergoing SVR is frequent and associated
with increased postoperative mortality. Comprehensive pre-
operative echocardiography is essential to characterize RV
function and can optimize patient selection for SVR.Conflict of Interest Statement
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